Midcap pharma stock falls on record date of bonus shares issue
Ajanta Pharma's board approved the issue of bonus equity shares in the ratio of 1:223-06-2022
23-06-2022
AJANTA PHARMA LTD. - 532331 - Intimation Of Annual General Meeting
Forty-Third (43rd) Annual General Meeting ('AGM') of the Company will be held on Thursday, 4th August 2022 at 11.00 a.m. through Video-conference or Other Audio-Visual Means.21-06-2022
3 upcoming bonus stocks to watch next week
Shareholders of Baid Leasing, Ajanta Pharma, and Nazara Technologies should be aware that the companies have announced a bonus issue, with the record date approaching shortly.18-06-2022
AJANTA PHARMA LTD. - 532331 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Ajanta Pharma Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here13-06-2022
AJANTA PHARMA LTD. - 532331 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Executive Committee of the Board of Directors has pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 fixed Thursday, 23rd June 2022 as the record date for the said corporate action. Kindly take the above intimation on your record and display the same on website of the Exchange.13-06-2022
AJANTA PHARMA LTD. - 532331 - Declaration Of Voting Results Of Postal Ballot Under Regulation 44 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 44(3) of the Listing Regulations, please find enclosed herewith voting results and the Scrutinizer''s Report thereon dated 13th June 2022. Kindly take the above on your records.13-06-2022
AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 03, 2022 for Ravi Agrawal, Trustee Ravi Agrawal Trust03-06-2022
AJANTA PHARMA LTD. - 532331 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information on loss of certificates30-05-2022
AJANTA PHARMA LTD. - 532331 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements), 2015
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions on a consolidated basis for the half-year ended 31st March 2022.20-05-2022
AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 16, 2022 for Ravi Agrawal, trustee Ravi Agrawal Trust16-05-2022